CXCL10



CXCL10

I1II1P2PP2L3LL3A4AA4R5RR5T6TT6V7VV7R8RR8C9CC9T10TT10C11CC11I12II12D13DD13F14FF14H15HH15E16EE16Q17QQ17P18PP18L19LL19R20RR20P21PP21R22RR22A23AA23I24II24G25GG25K26KK26L27LL27E28EE28I29II29I30II30P31PP31A32AA32S33SS33L34LL34S35SS35C36CC36P37PP37H38HH38V39VV39E40EE40I41II41I42II42A43AA43T44TT44M45MM45K46KK46K47KK47... and 30 more residue(s)...... and 30 more residue(s)

SMILES None
InChIKey None
Sequence IPLARTVRCTCIDFHEQPLRPRAIGKLEIIPASLSCPHVEIIATMKKNNEKRCLNPESEAIKSLLKAVSQRRSKRAP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CXCL10

I1II1P2PP2L3LL3A4AA4R5RR5T6TT6V7VV7R8RR8C9CC9T10TT10C11CC11I12II12D13DD13F14FF14H15HH15E16EE16Q17QQ17P18PP18L19LL19R20RR20P21PP21R22RR22A23AA23I24II24G25GG25K26KK26L27LL27E28EE28I29II29I30II30P31PP31A32AA32S33SS33L34LL34S35SS35C36CC36P37PP37H38HH38V39VV39E40EE40I41II41I42II42A43AA43T44TT44M45MM45K46KK46K47KK47... and 30 more residue(s)...... and 30 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.